Portage Biotech Inc.
PRTG
$5.53
-$0.50-8.29%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 40.47% | 34.67% | 27.98% | -728.94% | -736.68% |
| Total Depreciation and Amortization | 59.26% | 325.00% | 5,300.00% | 4,000.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.11% | -40.13% | -35.16% | 1,751.85% | 2,090.58% |
| Change in Net Operating Assets | -62.67% | 1,454.17% | 9,920.00% | -112.85% | 81.37% |
| Cash from Operations | 35.24% | 6.14% | -18.42% | -64.44% | -75.99% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 557.98% | 557.98% | 100.00% | 100.00% |
| Cash from Investing | -- | 555.75% | 555.75% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -147.06% | 97.91% | 98.00% | 98.60% | 99.15% |
| Issuance of Common Stock | 45.72% | 49.11% | 101.88% | 933.75% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 107.27% | 100.63% | 98.91% | 91.67% | 89.10% |
| Cash from Financing | 49.99% | 994.89% | 5,200.85% | 461.50% | 217.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.50% | 67.62% | 56.92% | 37.89% | 5.15% |
